Clinical Trial Update: A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

This Phase 3 trial compares prasugrel administration at PCI versus at diagnosis in non-ST-elevation acute coronary syndromes. The study is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Acute Coronary Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2014-02-28